EXACT Therapeutics Announces Appointment of Dr Per Walday as Chief Executive Officer
OSLO/LONDON, 28 March 2022: EXACT Therapeutics AS (“EXACT-Tx”, Euronext Growth: EXTX), a clinical stage precision health company utilising Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, announces that its Board of Directors has today appointed Dr Per Walday as Chief Executive Officer (CEO).
